500420 Stock Overview
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Torrent Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,685.00 |
| 52 Week High | ₹2,745.55 |
| 52 Week Low | ₹1,599.00 |
| Beta | 0.29 |
| 1 Month Change | 4.84% |
| 3 Month Change | 8.52% |
| 1 Year Change | 65.57% |
| 3 Year Change | 114.68% |
| 5 Year Change | 199.64% |
| Change since IPO | 8,492.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500420 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.8% | -0.5% | 1.4% |
| 1Y | 65.6% | 55.3% | 46.1% |
Return vs Industry: 500420 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 500420 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 500420 volatility | |
|---|---|
| 500420 Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 500420 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500420's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 13,247 | Samir Mehta | www.torrentpharma.com |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services.
Torrent Pharmaceuticals Limited Fundamentals Summary
| 500420 fundamental statistics | |
|---|---|
| Market cap | ₹908.73b |
| Earnings (TTM) | ₹14.94b |
| Revenue (TTM) | ₹104.74b |
60.8x
P/E Ratio8.7x
P/S RatioIs 500420 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500420 income statement (TTM) | |
|---|---|
| Revenue | ₹104.74b |
| Cost of Revenue | ₹27.11b |
| Gross Profit | ₹77.63b |
| Other Expenses | ₹62.69b |
| Earnings | ₹14.94b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 44.15 |
| Gross Margin | 74.12% |
| Net Profit Margin | 14.27% |
| Debt/Equity Ratio | 66.9% |
How did 500420 perform over the long term?
See historical performance and comparison